title: Multiple fragments of human TG are capable of inducing oral tolerance to whole human TG.
abstract: Oral tolerance is the mechanism by which the immune system remains unresponsive to orally administered soluble antigens. Mice immunized with human TG (hTG), resulting in the induction of experimental autoimmune thyroiditis (EAT), provide an ideal in vivo system in which to examine oral tolerance to hTG. In the present study, we characterize epitopes of hTG that are capable of inducing oral tolerance. hTG is a large homodimeric protein, 660 Kd. The limited proteolysis of hTG using trypsin (TR) generates several smaller fragments of hTG ranging in size from 29 Kd to 145 Kd. Using hTG fragments h1TR (residues 1-521), h4bisTR (residues 2513-2713), h6TR (residues 522-1626), and h7TR (residues 1627-2512), prepared from both iodine rich and iodine poor hTG, we investigated the ability of these fragments to induce oral tolerance. The oral administration of iodine rich h6TR or h7TR suppresses hTG specific immune responses in a manner similar to whole hTG. In contrast, the oral administration of iodine rich h1TR or h4bisTR exacerbates hTG specific immune responses. Unlike iodine rich h1TR or h4bisTR, the oral administration of iodine poor h1TR or h4bisTR fails to augment hTG specific immune responses. In fact, h4bisTR suppresses hTG specific immune responses. These results indicate that hTG contains multiple epitopes that differentially affect oral tolerization. Tolerogenic epitopes reside within fragments h6TR and h7TR. The removal of iodine, and presumably hormone, from h4bisTR converts an immunogenic epitope to a tolerogenic epitope.
authors.affiliation: Thyroid Study Unit, MC 3090, Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Gardine
authors.forename: F
authors.initials: F
authors.lastname: Gentile
authors.forename: C
authors.initials: C
authors.lastname: Pellegrini
authors.forename: F
authors.initials: F
authors.lastname: Giallauria
authors.forename: G
authors.initials: G
authors.lastname: Torelli
authors.forename: T
authors.initials: T
authors.lastname: Kouki
authors.forename: L
authors.initials: L
authors.lastname: DeGroot
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000917:Antibody Formation / Q000276:immunology; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D007455:Iodine / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D008808:Mice, Inbred CBA; D010446:Peptide Fragments / Q000008:administration & dosage / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D013954:Thyroglobulin / Q000008:administration & dosage / Q000276:immunology*; D013967:Thyroiditis, Autoimmune / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy
chemical_list: D010446:Peptide Fragments; D013954:Thyroglobulin; D007455:Iodine